Osmofundin® 15% N / Mannitol 15%
Administration for the prevention of acute renal failure (after positive response to test infusion), reduction of intracranial pressure and supportive systemic therapy of acute glaucoma.
Administration for the prevention of acute renal failure (after positive response to test infusion), reduction of intracranial pressure and supportive systemic therapy of acute glaucoma.